Fallopian Tube Mucinous Adenocarcinoma
NCI Definition: An extremely rare adenocarcinoma that arises from the fallopian tube. It is characterized by the presence of neoplastic epithelial cells that contain intracytoplasmic mucin. The cases that have been reported are predominantly in situ mucinous adenocarcinomas. 
There is 1 clinical trial for fallopian tube mucinous adenocarcinoma, of which 1 is open and 0 are completed or closed. Of the trial that contains fallopian tube mucinous adenocarcinoma as an inclusion criterion, 1 is phase 1/phase 2 (1 open).
Carboplatin, defactinib, and paclitaxel are the most common interventions in fallopian tube mucinous adenocarcinoma clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.